Here is the latest shareholding Pattern of RAJNISH WELLNESS. For more details, see the RAJNISH WELLNESS financial fact sheet and RAJNISH WELLNESS share price.
No. of Mths Qtr. Ending |
3
Dec-22 |
3
Mar-23 |
3
Jun-23 |
3
Sep-23 |
3
Dec-23 |
3
Mar-24 |
3
Jun-24 |
3
Sep-24 |
||
---|---|---|---|---|---|---|---|---|---|---|
Indian Promoters | % | 16.05 | 16.05 | 16.24 | 16.24 | 16.24 | 16.24 | 16.24 | 16.24 | |
Foreign Promoters | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Promoters | % | 16.05 | 16.05 | 16.24 | 16.24 | 16.24 | 16.24 | 16.24 | 16.24 | |
Mutual Funds | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Financial institution/Banks/Insurance | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Government | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
FII | % | 0.00 | 0.08 | 0.00 | 0.00 | 0.00 | 1.09 | 1.20 | 0.20 | |
Other | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Institution | % | 0.00 | 0.08 | 0.00 | 0.00 | 0.00 | 1.09 | 1.20 | 0.20 | |
Bodies Corporate | % | 62.48 | 61.31 | 58.56 | 58.83 | 56.16 | 48.37 | 43.34 | 28.95 | |
Individuals | % | 20.05 | 20.91 | 23.10 | 23.08 | 25.58 | 31.21 | 35.61 | 51.26 | |
NRIs/OCBs | % | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 | 0.14 | 0.18 | 0.40 | |
ADR/GDR | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Others | % | 1.39 | 1.62 | 2.07 | 1.81 | 1.98 | 2.95 | 3.43 | 2.96 | |
Total Non-Institution | % | 83.95 | 83.87 | 83.76 | 83.76 | 83.76 | 82.67 | 82.56 | 83.57 | |
Total Public | % | 84.00 | 84.00 | 84.00 | 84.00 | 84.00 | 84.00 | 84.00 | 84.00 | |
Grand Total | % | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
Pledged Promoter Holding | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Subscriber Feature |
More Pharmaceuticals Company Shareholding Pattern: UPL PIDILITE INDUSTRIES HIMADRI SPECIALITY CHEMICAL TATA CHEMICALS RCF
On Thursday, Indian share markets traded lower throughout the trading session and ended on a weak note.